Gilead Sciences (GILD) Tops Q4 EPS by 17c; Guides
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $125.59 -0.22%
EPS Growth %: -427.9%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -427.9%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $1.67, $0.17 better than the analyst estimate of $1.50. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $6.66 billion.
GUIDANCE:
Gilead Sciences sees FY2023 EPS of $6.60-$7.00, versus the consensus of $6.73. Gilead Sciences sees FY2023 revenue of $26-26.5 billion, versus the consensus of $27 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Oxford Industries (OXM) Tops Q1 EPS by 12c; Offers Outlook
- Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
